Bay Area's Global Blood Therapeutics Terminates Lung Disease Program
The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF). Source: BioSpace
GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and …
Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace
FDA Calls Novartis' Melanoma Combo Drug a Breakthrough
The FDA based its decision on data from the COMBI-AD Phase III trial. Source: BioSpace
DBV Technologies Crashed as Allergy Drug Flunked Phase III Test
DBV's share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo. Source: BioSpace
Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group
Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace
The 5 Key Drugs That Need to Keep Performing to Keep Johnson & Johnson on Top
If J&J's going to keep rewarding investors, it's going to need these top drugs to continue racking up sales. Source: BioSpace
Eli Lilly to Invest $72M in Indianapolis Diabetes Manufacturing
In order to meet growing demand for insulin, pharma giant Eli Lilly said it will invest $72M to expand insulin manufacturing capabilities at one of its Indianapolis facilities. Source: BioSpace
Company Failed to Check Out Patient’s Drug Complaint, FDA Says
A Texas drugmaker was flagged by the FDA for failing to follow up on a patient’s complaint. Source: Drug Industry Daily
EU GMP Measures for Drugs, Clinical Trials Added to Legal Code
The European Commission formally adopted updated regulations on good manufacturing practices for pharmaceuticals generally and for investigational drugs and clinical trials more specifically. Source: Drug Industry Daily
Indian Generics Manufacturer Fails to Meet Standards, UK Inspectors Say
UK regulators moved to block imports to the European Union from a generic drug manufacturer in India after reporting deficiencies in quality control, processing, laboratory testing and safeguards against contamination.…
- Go to the previous page
- 1
- …
- 281
- 282
- 283
- 284
- 285
- 286
- 287
- …
- 610
- Go to the next page